000 01369 a2200373 4500
005 20250518035719.0
264 0 _c20190911
008 201909s 0 0 eng d
022 _a1179-1918
024 7 _a10.1007/s40261-019-00790-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCiruelos, Eva
245 0 0 _aMaintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept.
_h[electronic resource]
260 _bClinical drug investigation
_cJul 2019
300 _a595-606 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBevacizumab
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCapecitabine
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPrognosis
650 0 4 _aQuality of Life
650 0 4 _aReceptor, ErbB-2
_xmetabolism
650 0 4 _aRemission Induction
650 0 4 _aRetrospective Studies
700 1 _aPérez-García, José Manuel
700 1 _aGavilá, Joaquín
700 1 _aRodríguez, Analía
700 1 _ade la Haba-Rodriguez, Juan
773 0 _tClinical drug investigation
_gvol. 39
_gno. 7
_gp. 595-606
856 4 0 _uhttps://doi.org/10.1007/s40261-019-00790-9
_zAvailable from publisher's website
999 _c29656341
_d29656341